There areresults for 'Funding'
New Pharma Rankings On Global Access To Medicine Released
Merck Global Health Institute partners up to accelerate R&D for bacterial infections, schistosomiasis and malaria
Systematic approach to identify access challenges
Five companies are carrying out 63% of the most urgently needed R&D projects
Access planning: How do pharmaceutical companies plan to make new products quickly accessible after launch?
The Africa Non-Communicable Disease (NCD) Open Lab advances NCD research
Academy supports local scientists in Uganda
Cross-sector partnership drives early-stage R&D
Majority of key on-patent products have access initiatives, but these are limited in reach
View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.